Related Experiment Video
Updated: Apr 19, 2026

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
Published on: October 10, 2025
The first trimester: prediction and prevention of the great obstetrical syndromes
Arianne Sweeting1, Felicity Park2, Jon Hyett3
1Faculty of Medicine, University of Sydney, Sydney, NSW, Australia; Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Insights
Screening for pre-eclampsia and gestational diabetes in the first trimester shows promise. Early detection through combined screening methods may improve maternal and neonatal outcomes by enabling timely therapeutic interventions.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Reproductive Health
Background:
- Current research explores early screening for pre-eclampsia and gestational diabetes at 12 weeks' gestation.
- This aligns with existing first-trimester aneuploidy screening protocols.
- Utilizing regression analysis to integrate demographic and investigative data is a key approach.
Purpose of the Study:
- To evaluate the feasibility and potential of early screening for pre-eclampsia and gestational diabetes.
- To assess the integration of this screening into first-trimester aneuploidy screening.
- To identify methods for improving maternal and neonatal outcomes through early detection.
Main Methods:
- Employing regression analysis to combine multiple demographic and investigative factors.
- Integrating screening for pre-eclampsia and gestational diabetes with combined first-trimester screening for aneuploidy.
- Analyzing data from early gestation (12 weeks).
Main Results:
- Research into pre-eclampsia prediction is currently more robust.
- Early screening holds potential for therapeutic intervention.
- Improved maternal and neonatal outcomes are anticipated with effective early detection.
Conclusions:
- First-trimester screening for pre-eclampsia and gestational diabetes is under investigation.
- Robust prediction models for pre-eclampsia offer opportunities for intervention.
- Early detection strategies aim to enhance maternal and neonatal health outcomes.
Abstract:
A number of groups are currently examining the potential of screening for pre-eclampsia and gestational diabetes at 12 weeks' gestation. This can be performed at the time of combined first-trimester screening for aneuploidy using a similar method of regression analysis to combine multiple demographic and investigative factors. At present, research into the prediction of pre-eclampsia is more robust and is associated with the potential for therapeutic intervention that can reduce the prevalence of early-onset pre-eclampsia and improve maternal and neonatal outcomes.
Related Concept Videos
Teratogenicity
Preventive Healthcare Services
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Development of the Oral Microbiota
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

